Last reviewed · How we verify

NCT02869854: FAR-MIND

Increased Physical Activity Through Mindfulness

Completed NA Results posted Last updated 16 April 2025
What this trial tests

NA trial testing Mindfulness in Physical Activity in 88 participants. Completed in 18 December 2018.

Timeline
30 September 2016
Primary endpoint
18 December 2018
18 December 2018

Quick facts

Lead sponsorRegion Skane
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment88
Start date30 September 2016
Primary completion18 December 2018
Estimated completion18 December 2018
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Region Skane — full company profile →

Who can join

Adults 40 to 65, any sex, with Physical Activity or Life Style. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Difference in Percentage of Time Spent Per Physical Activity Level Per Week of Time, Between the Three Different Groups Measured by Activity Monitor Actigraph (GT3X) Primary · Baseline ,6 months.

Each individual will wear an activity monitor for 7 days. This will be done at baseline and after 6 months. The difference in the time of physical activity level was measured in minutes of activity during a week and then divided into percentages of sedentary time, light physical activity time and moderate to vigourous physical activity time, measured by activity monitor Actigraph (GT3X). In the analysis

Baseline:Percent of time in sedentary time
GroupValue95% CI
PAP Only66.2± 6.7
Mindfulness Only65.5± 9.2
Combination of the Two Groups66.7± 8.8
Baseline:Percent of time in LIPA
GroupValue95% CI
PAP Only30.9± 6.2
Mindfulness Only31.7± 8.2
Combination of the Two Groups30.3± 8.0
Baseline:Percent of time in MVPA
GroupValue95% CI
PAP Only2.6± 0.18
Mindfulness Only2.3± 0.02
Combination of the Two Groups2.4± 0.02
6 months:Percent of time in sedentary time
GroupValue95% CI
PAP Only65.0± 6.8
Mindfulness Only65.9± 9.4
Combination of the Two Groups64.0± 9.1
6 months Percent of LIPA
GroupValue95% CI
PAP Only32.0± 5.8
Mindfulness Only31.6± 9.0
Combination of the Two Groups32.8± 8.9
6 months: Percent of MVPA
GroupValue95% CI
PAP Only2.6± 0.02
Mindfulness Only1.9± 0.02
Combination of the Two Groups2.7± 0.02
Difference Between the Three Groups in Revised Assessment of Their Self-rated Health Secondary · base-line ,3 months, 6 months

assessment based on terms of perceived health with five alternative answers, a higher score incdicates a better outcome 1. very poor 2. poor 3. fair 4. good 5. very good

Baseline
GroupValue95% CI
PAP Only31 – 4
Mindfulness Only32 – 5
Combination of the Two Groups32 – 5
3 months
GroupValue95% CI
PAP Only31 – 4
Mindfulness Only32 – 5
Combination of the Two Groups42 – 5
6 months
GroupValue95% CI
PAP Only41 – 4
Mindfulness Only42 – 5
Combination of the Two Groups42 – 5
Difference Between Groups in the Amount of Self-perceived Sleep Problems Secondary · Baseline, 3 months, 6 months

Insomnia Severity Index(ISI); is a self-report questionnaire measuring insomnia symptoms to evaluate the degree of insomnia. The scale consists of seven questions that evaluate Sleep mode, sleep during the night, waking up early, the feeling of being rested, how sleeping problems affect daily life, and how sleep patterns concern the individual. The higher the score, the better the outcome. Minimun score = 0, Maximum score = 28

Insomnia Severity Index baseline
GroupValue95% CI
PAP Only80 – 24
Mindfulness Only110 – 27
Combination of the Two Groups100 – 21
Insomnia Severity Index 3 months
GroupValue95% CI
PAP Only70 – 20
Mindfulness Only110 – 27
Combination of the Two Groups90 – 27
Insomnia Severity Index 6 months
GroupValue95% CI
PAP Only60 – 18
Mindfulness Only130 – 25
Combination of the Two Groups90 – 18

Sponsor's own description

In a pilot study, 90 physically inactive patients will be opportunistically and consecutively recruited and randomized to three intervention groups: mindfulness training, Physical Activity on Prescription (PAP) or only PAP. Follow-up will be done at baseline, three and six months with questionnaires, accelerometers and analysis of traditional risk factors to evaluate whether mindfulness may increase physical activity and decrease physical inactivity.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effect of mindfulness on physical activity in primary healthcare patients: a randomised controlled trial pilot study.
    Nymberg P, Calling S, Stenman E, Palmér K, et al · · 2021 · cited 3× · PMID 33731219 · DOI 10.1186/s40814-021-00810-6
  2. Pilot study on increased adherence to physical activity on prescription (PAP) through mindfulness: study protocol.
    Nymberg P, Ekvall Hansson E, Stenman E, Calling S, et al · · 2018 · cited 2× · PMID 30333052 · DOI 10.1186/s13063-018-2932-9
  3. Effect of mindfulness on physical activity in primary healthcare patients: a randomised controlled trial pilot study.
    Nymberg P, Calling S, Stenman E, Palmér K, et al · · 2020 · DOI 10.21203/rs.3.rs-23021/v2

Verify or expand the search:

Other trials of Mindfulness

Trials testing the same drug.

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other Region Skane trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02869854.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing